Skip to content
You are now leaving to visit

Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors

CAMBRIDGE, Mass. , April 17, 2018 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. , today announced that, following today’s close of the transaction licensing Akcea the exclusive, worldwide rights to inotersen and AKCEA-TTR-L Rx , Sarah Boyce